tirzepatide weight loss orlando lake ivanhoe Injections GLP-1 Tirzepatide for Weight Loss

While preclinical studies suggest GLP-1 receptor signaling may influence gut barrier function and inflammation, these findings have not been confirmed in human clinical trials

Maintenance dosing is typically lower than the maximum dose reached during active weight loss

Glucagon-like peptide-1 (736 amide) secretion in response to luminal sucrose from the upper and lower gut Scand J Gastroenterol 1995 30 : 892896

Those selected will receive weekly injections of either semaglutide or a placebo over a 24-week treatment period, followed by a subsequent safety follow-up phase

This is due to semaglutides dual action of reducing appetite and slowing gastric emptying

No meaningful glycemic benefit is expected at 0.25 mg